Skip to main content

Table 2 Distribution of Fib-4 scores in coded NAFLD/NASH patients shown for each country database

From: Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts

Risk category

HSD Italy (%)

IPCI Netherlands (%)

SIDIAP Spain (%)

THIN UK (%)

Total population (%)

Low (< 1.30)

64.7

69.7

65.3

63.4

65.4

Indeterminate (1.30–2.67)

31.0

26.6

30.1

26.2

29.8

High (> 2.67)

4.3

3.7

4.6

10.5

4.7

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us